Cabazitaxel
Cabazitaxel

Cabazitaxel

Catalog NumberPI1402820625

CAS Number1402820-62-5

CategoryAntineoplastic Agents

Derived from needles of yew trees, cabazitaxel is prescribed for the treatment of patients with hormone-refractory prostate cancer (HRPC) that has spread to other parts of the body and was previously treated with a docetaxel-containing treatment regimen. It is used in combination with prednisone. HRPC is a prostate cancer that has become unresponsive to hormonal manipulation.Cabazitaxel is administered intravenously.
Cabazitaxel

* Our products are for research use only.

Get in Touch

We're glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2